Summary
Hi-Tech Pharmacal Co., Inc. (Hi-Tech Pharmacal) is a pharmaceutical company. The company develops, manufactures and markets generic prescription, over-the-counter and nutritional products. It offers products such as vitamin D supplement, albuterol sulfate, gabapentin oral solution, lactulose solution, levofloxacin oral solution, neomycin sulfate tablets, valproic acid oral solution, and others. Hi-Tech Pharmacal offers its products for use in therapeutic areas of glaucoma, asthma, bronchial disorders, dermatological disorders, allergies, pain, stomach, and oral care among others. The company supplies its products to chain drug stores, generic medicine distributors, mass merchandisers, drug wholesalers, federal government agencies, and mail-order pharmacies. Hi-Tech Pharmacal is headquartered in Amityville, New York, the US.
Hi-Tech Pharmacal Co., Inc. Pharmaceuticals & Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
Financial Deals Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
Deals by Sub-sector Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
Major Deals Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
Business Description A brief description of the companys operations.
Key Employees A list of the key executives of the company.
Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company.
Key Competitors A list of the key competitors of the company.
Key Recent Developments A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Hi-Tech Pharmacal Co., Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 4
Hi-Tech Pharmacal Co., Inc., Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015 6
Hi-Tech Pharmacal Co., Inc., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 7
Hi-Tech Pharmacal Co., Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015 8
Hi-Tech Pharmacal Co., Inc., Medical Devices Deals, 2009 to YTD 2015 9
Hi-Tech Pharmacal Co., Inc., Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015 10
Hi-Tech Pharmacal Co., Inc., Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Hi-Tech Pharmacal Acquires Rights To Cormax From Watson Labs 12
Hi-Tech Pharmacal Acquires Homeopathic Nasal Spray Products From Dynova Labs 13
Hi-Tech Pharmacal Acquires Rights To Branded Products From Atley Pharma 14
Hi-Tech Pharmacal Acquires Nystatin Oral Suspension ANDA From Bausch & Lomb 15
Hi-Tech Pharmacal Acquires Mag-Ox Line Of Magnesium Supplements From Blaine Pharma 16
Partnerships 17
Hi-Tech Pharmacal Enters Into Co-Marketing Agreement With Mallinckrodt For TussiCaps 17
Elite Pharma Enters Into Co-Development Agreement With Hi-Tech Pharmacal 19
Licensing Agreements 20
Hi-Tech Pharmacal Enters Into Licensing Agreement With Septodont For Lidocaine 5% Ointment 20
Hi-Tech Pharmacal Enters Into Licensing Agreement With Glycobiosciences For Hylase Wound Gel 21
Hi-Tech Pharmacal Enters Into Licensing Agreement With KVK-Tech For Lodrane 22
Hi-Tech Pharmacal Enters Into Licensing Agreement With Mission Pharmacal 23
Equity Offering 24
Hi-Tech Pharmacal Files Registration Statement For Public Offering Of US$100 Million 24
Asset Transactions 26
Actavis Acquires Four Generic Products From Akorn And Hi-Tech Pharmacal 26
Acquisition 28
Akorn Completes Acquisition Of Hi-Tech Pharmacal For US$640 Million 28
Metrics Acquires Midlothian Labs From Hi-Tech Pharmacal 31
Hi-Tech Pharmacal Acquires ECR Pharma 32
Hi-Tech Pharmacal Co., Inc. - Key Competitors 33
Key Employees 34
Locations And Subsidiaries 35
Head Office 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36
List Of Tables
List of Tables
Hi-Tech Pharmacal Co., Inc., Pharmaceuticals & Healthcare, Key Facts, 2013 1
Hi-Tech Pharmacal Co., Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 5
Hi-Tech Pharmacal Co., Inc., Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015 6
Hi-Tech Pharmacal Co., Inc., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 7
Hi-Tech Pharmacal Co., Inc., Deals By Therapy Area, 2009 to YTD 2015 8
Hi-Tech Pharmacal Co., Inc., Medical Devices Deals, 2009 to YTD 2015 9
Hi-Tech Pharmacal Co., Inc., Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015 10
Hi-Tech Pharmacal Acquires Rights To Cormax From Watson Labs 12
Hi-Tech Pharmacal Acquires Homeopathic Nasal Spray Products From Dynova Labs 13
Hi-Tech Pharmacal Acquires Rights To Branded Products From Atley Pharma 14
Hi-Tech Pharmacal Acquires Nystatin Oral Suspension ANDA From Bausch & Lomb 15
Hi-Tech Pharmacal Acquires Mag-Ox Line Of Magnesium Supplements From Blaine Pharma 16
Hi-Tech Pharmacal Enters Into Co-Marketing Agreement With Mallinckrodt For TussiCaps 17
Elite Pharma Enters Into Co-Development Agreement With Hi-Tech Pharmacal 19
Hi-Tech Pharmacal Enters Into Licensing Agreement With Septodont For Lidocaine 5% Ointment 20
Hi-Tech Pharmacal Enters Into Licensing Agreement With Glycobiosciences For Hylase Wound Gel 21
Hi-Tech Pharmacal Enters Into Licensing Agreement With KVK-Tech For Lodrane 22
Hi-Tech Pharmacal Enters Into Licensing Agreement With Mission Pharmacal 23
Hi-Tech Pharmacal Files Registration Statement For Public Offering Of US$100 Million 24
Actavis Acquires Four Generic Products From Akorn And Hi-Tech Pharmacal 26
Akorn Completes Acquisition Of Hi-Tech Pharmacal For US$640 Million 28
Metrics Acquires Midlothian Labs From Hi-Tech Pharmacal 31
Hi-Tech Pharmacal Acquires ECR Pharma 32
Hi-Tech Pharmacal Co., Inc., Key Competitors 33
Hi-Tech Pharmacal Co., Inc., Key Employees 34
List Of Figures
List of Figures
Hi-Tech Pharmacal Co., Inc., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015 1
Hi-Tech Pharmacal Co., Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 1
Hi-Tech Pharmacal Co., Inc., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 1
Hi-Tech Pharmacal Co., Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015 1
Hi-Tech Pharmacal Co., Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 5
Hi-Tech Pharmacal Co., Inc., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015 6
Hi-Tech Pharmacal Co., Inc., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 7
Hi-Tech Pharmacal Co., Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015 8
Hi-Tech Pharmacal Co., Inc., Medical Devices Deals, 2009 to YTD 2015 9
